Rusul Almter

Papers

Total Citations

H-Index

About

Rusul Almter is at the forefront of advancing preclinical cancer research through automation, with a focused expertise in microinjection technologies for zebrafish xenograft models. Her work directly addresses a critical bottleneck in translational oncology: the labor-intensive, manual injection of cancer cells into zebrafish larvae. By developing automated microinjection systems, Almter has significantly enhanced the reproducibility, precision, and throughput of these models, which are increasingly recognized for their power in predicting patient-specific responses to cancer therapeutics. Her most-cited paper (2025, 5 citations) and a closely related 2024 study (2 citations) collectively lay the groundwork for transforming zebrafish xenografts from a specialized research tool into a viable clinical diagnostic platform. This pioneering automation not only reduces human error and labor but also accelerates the pace of drug screening and personalized medicine studies. Almter’s contributions are pivotal for researchers seeking high-throughput, reliable in vivo models, positioning her as a key innovator in the intersection of bioengineering and cancer biology. Her work promises to make zebrafish-based diagnostics more accessible and scalable for clinical applications.